188 related articles for article (PubMed ID: 22115712)
1. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.
Cohen AE; Assang C; Patane MA; From S; Korenfeld M;
Ophthalmology; 2012 Jan; 119(1):66-73. PubMed ID: 22115712
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
Sheppard J; Garg S; Lievens C; Brandano L; Wirostko B; Korenfeld M; Raizman M; Foster CS
Am J Ophthalmol; 2020 Mar; 211():76-86. PubMed ID: 31726034
[TBL] [Abstract][Full Text] [Related]
3. Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial.
Papangkorn K; Truett KR; Vitale AT; Jhaveri C; Scales DK; Foster CS; Montieth A; Higuchi JW; Brar B; Higuchi WI
Curr Eye Res; 2019 Feb; 44(2):185-193. PubMed ID: 30354530
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits.
Patane MA; Schubert W; Sanford T; Gee R; Burgos M; Isom WP; Ruiz-Perez B
J Ocul Pharmacol Ther; 2013 Oct; 29(8):760-9. PubMed ID: 23844757
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery: A Randomized, Placebo-Controlled, Phase III Trial.
Donnenfeld E; Holland E
Ophthalmology; 2018 Jun; 125(6):799-806. PubMed ID: 29397189
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications.
Perez VL; Wirostko B; Korenfeld M; From S; Raizman M
J Ocul Pharmacol Ther; 2020 Mar; 36(2):75-87. PubMed ID: 31755807
[No Abstract] [Full Text] [Related]
7. Phase II results of an intraocular steroid delivery system for cataract surgery.
Chang DF; Garcia IH; Hunkeler JD; Minas T
Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
O'Neil EC; Huang J; Suhler EB; Dunn JP; Perez VL; Gritz DC; McWilliams K; Peskin E; Ying GS; Bunya VY; Maguire MG; Kempen JH
Br J Ophthalmol; 2018 Aug; 102(8):1011-1013. PubMed ID: 29666122
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
Williams GA; Haller JA; Kuppermann BD; Blumenkranz MS; Weinberg DV; Chou C; Whitcup SM;
Am J Ophthalmol; 2009 Jun; 147(6):1048-54, 1054.e1-2. PubMed ID: 19268890
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study.
Nirschl RP; Rodin DM; Ochiai DH; Maartmann-Moe C;
Am J Sports Med; 2003; 31(2):189-95. PubMed ID: 12642251
[TBL] [Abstract][Full Text] [Related]
16. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
Sheppard JD; Toyos MM; Kempen JH; Kaur P; Foster CS
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2993-3002. PubMed ID: 24677110
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery.
Rajpal RK; Roel L; Siou-Mermet R; Erb T
J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817
[TBL] [Abstract][Full Text] [Related]
18. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery.
Tyson SL; Bafna S; Gira JP; Goldberg DF; Jones JJ; Jones MP; Kim JK; Martel JM; Nordlund ML; Piovanetti-Perez IK; Singh IP; Metzinger JL; Mulani D; Sane S; Talamo JH; Goldstein MH;
J Cataract Refract Surg; 2019 Feb; 45(2):204-212. PubMed ID: 30367938
[TBL] [Abstract][Full Text] [Related]
19. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.
Kuppermann BD; Blumenkranz MS; Haller JA; Williams GA; Weinberg DV; Chou C; Whitcup SM;
Arch Ophthalmol; 2007 Mar; 125(3):309-17. PubMed ID: 17353400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
